Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000941:Antigens / Q000008:administration & dosage; D002464:Cell Migration Inhibition; D003168:Complement Fixation Tests; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007111:Immunity, Cellular; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008470:Meconium / Q000276:immunology; D008875:Middle Aged; D009132:Muscles / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology*; D009218:Myosins / Q000032:analysis; D013934:Thymectomy; D013950:Thymus Gland / Q000473:pathology
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D000941:Antigens; D003609:Dactinomycin; D009218:Myosins